CVC Buys 20,000 Recordati Shares at EUR 53 Each

BRIEF-Cogent Biosciences Q3 Income From Operations USD -117.184 Million Nov 05 (Reuters) - Cogent Biosciences Q3 operating expenses USD 117.184 million. L impact | FX | Nov 05, 2026, 09:04 PM UTC

Recordati, CVC acquista 20.000 azioni a 53 euro ciascuna Recordati, CVC acquista 20.000 azioni a 53 euro ciascuna L’investitore CVC ha acquistato il 5 no L impact | FX | Nov 05, 2026, 07:01 PM UTC

US Dollar Nudges Higher Against Loonie as Yields Fall, Oil Jumps The US dollar edged higher against the Canadian dollar. Bond yields fell and oil prices rose. M impact | FX | Nov 05, 2026, 06:49 PM UTC

Form SCHEDULE 13G STERLING INFRASTRUCTURE, Filed by: FMR LLC Filed on: November 5, 20 L impact | FX | Nov 05, 2026, 06:28 PM UTC

SOL Strategies Clarifies KCSA Investor Relations Deal Carries USD 10,000 Monthly Fee SOL Strategies Clarifies KCSA Investor Relations Deal Carries USD 10,000 Monthly Fee Sol Strateg L impact | FX | Nov 05, 2026, 06:16 PM UTC

Nuinsco Resources Engages CHF Capital Markets for Investor Relations Services Nuinsco Resources Engages CHF Capital Markets for Investor Relations Services (TheNewswire) Toronto L impact | FX | Nov 05, 2026, 06:04 PM UTC

CVC Buys 20,000 Recordati Shares at EUR 53 Each

Related stories